首页> 外文期刊>Journal of Pharmacological and Toxicological Methods >Development, validation, and application of a novel 7-day Caco-2 cell culture system
【24h】

Development, validation, and application of a novel 7-day Caco-2 cell culture system

机译:新型7天Caco-2细胞培养系统的开发,验证和应用

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Monolayers of Caco-2 cells have been widely accepted as one of the well-established in vitro models to predict intestinal drug permeability and absorption in humans. However, the procedure for culturing the traditional 21-day Caco-2 model is labor intensive and time consuming, which limits its wide application in drug development. The objective of the present study was to develop a rapid Caco-2 model with a 7-day cell culture process. Methods: A few modifications of the BIOCOAT? HTS Caco-2 Assay System were introduced including changing the cell seeding density, the composition of cell culture media, and the interval to change media. The monolayer structure was visualized through confocal microscopy. The transepithelial electrical resistance (TEER), apparent permeability coefficients (Papp), and functional activity of P-glycoprotein (P-gp) were determined and compared with the 21-day model. Moreover, pharmacokinetic studies were performed in animal models to evaluate the absolute bioavailability of oral doses (Foral) of different compounds. Results: Our newly developed 7-day Caco-2 model displayed comparable cellular morphology and integrity with the traditional 21-day model. No significant difference in paracellular and transcellular permeability was observed between the two systems. The efflux ratios of transporting digoxin, the prototypical substrate of P-gp in 21- and 7-day systems were 16.04 and 24.92, respectively. When the P-gp inhibitor verapamil was present, the efflux ratios of 21- and 7-day systems were 1.37 and 0.86, respectively, suggesting the comparability of the P-gp functional activity in both systems. Furthermore, pharmacokinetic studies of several compounds performed in animal models revealed that the absolute bioavailability of oral doses in vivo was well correlated with the Caco-2 permeability in vitro. Discussion: The novel system provides a rapid and economical option for assessing the drug permeability, and is applicable to the studies of intestinal drug absorption.
机译:简介:单层Caco-2细胞已被广泛接受,是一种成熟的体外模型,可以预测人体对肠道药物的渗透性和吸收性。但是,培养传统的21天Caco-2模型的过程需要大量劳动和时间,这限制了其在药物开发中的广泛应用。本研究的目的是开发具有7天细胞培养过程的快速Caco-2模型。方法:BIOCOAT的一些修改?引入了HTS Caco-2分析系统,包括改变细胞接种密度,细胞培养基的组成以及改变培养基的间隔。通过共聚焦显微镜观察单层结构。测定跨上皮电阻(TEER),表观通透系数(Papp)和P-糖蛋白(P-gp)的功能活性,并与21天模型进行比较。此外,在动物模型中进行了药代动力学研究,以评估不同化合物口服剂量(Foral)的绝对生物利用度。结果:我们新开发的7天Caco-2模型显示出与传统21天模型相当的细胞形态和完整性。在两个系统之间没有观察到细胞旁和跨细胞通透性的显着差异。在21天和7天系统中,运输地高辛(P-gp的原型底物)的外排比分别为16.04和24.92。当存在P-gp抑制剂维拉帕米时,第21天和第7天系统的流出比分别为1.37和0.86,表明这两个系统中P-gp功能活性的可比性。此外,在动物模型中进行的几种化合物的药代动力学研究表明,体内口服剂量的绝对生物利用度与体外Caco-2渗透性密切相关。讨论:该新型​​系统为评估药物的渗透性提供了一种快速而经济的选择,并适用于肠道药物吸收的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号